Breakthrough Weight Loss Treatment: Amgen's Latest Drug Leads to 20% Reduction in Body Weight in New Study

In a groundbreaking development in the field of obesity treatment, a recent study has demonstrated that an experimental drug from Amgen has the potential to help patients lose up to 20% of their body weight over the course of a year. This remarkable achievement could significantly change the landscape for obesity management, offering hope to millions of individuals struggling with weight-related health issues.

Continue reading

Amgen Reports Stronger-Than-Expected Profit Amid Lower Costs

Biotechnology giant Amgen has recently announced robust quarterly earnings that exceeded analysts' expectations, primarily driven by lower-than-anticipated production costs. The company's financial performance showcases its ability to navigate through challenging economic conditions while maintaining profitability.

Continue reading